Peak Bio, Inc. (PKBO)

Peak Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2022	2021
Market Capitalization	0	74	167
Market Cap Growth	-91.50%	-55.61%	-
Enterprise Value	8	79	168
PE Ratio	-	-5.67	-20.16
PS Ratio	0.31	122.12	316.42
PB Ratio	-0.87	-9.17	-86.38
P/FCF Ratio	-2.14	-9.73	-18.84
P/OCF Ratio	-2.14	-9.91	-18.86
EV/Sales Ratio	12.17	130.27	318.87
EV/EBITDA Ratio	-1.50	-6.66	-18.95
EV/EBIT Ratio	-1.48	-6.25	-18.58
EV/FCF Ratio	-3.08	-10.38	-18.98
Debt / Equity Ratio	-0.39	-0.69	-0.78
Debt / EBITDA Ratio	-0.47	-0.47	-0.17
Debt / FCF Ratio	-0.97	-0.73	-0.17
Quick Ratio	0.01	0.06	0.07
Current Ratio	0.08	0.30	0.16
Asset Turnover	0.09	0.08	0.49
Interest Coverage	-2.67	-247.05	-790.30
Return on Equity (ROE)	132.95%	161.70%	428.50%
Return on Assets (ROA)	-1430.76%	-173.83%	-769.07%
Return on Capital (ROIC)	174.78%	475.45%	2082.75%
Earnings Yield	-13335.64%	-17.64%	-4.96%
FCF Yield	-4082.17%	-10.28%	-5.31%
Buyback Yield / Dilution	-0.98%	-3.20%	-
Total Shareholder Return	-0.98%	-3.20%	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.